Age, comorbidity, treatment decision and prognosis in lung cancer

Age and Ageing

Volumn 37, Issue 6, 2008, Pages 715-718

  Blanco, José Antonio Gullón ^a   Toste, Isabel Suárez ^a   Alvarez, Ramón Fernández ^a   Cuadrado, Gemma Rubinos ^a   Gonzalvez, Agustín Medina ^a   Martín, Isidro Jesús González ^a  

^a NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; WEIGHT REDUCTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DRUG THERAPY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 56749181439     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afn226     Document Type: Letter

References (23)

1. Sánchez de Cos J, Miravet L, Abal J et al. The EpicliCP-2003 Study: A Multicenter Epidemiological and Clinical Study of Lung Cancer in Spain. Arch Bronconeumol 2006; 42: 446-52.
2. Bunn PA, Lilenbaum R. Chemotherapy for elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 2003; 95: 341-3.
3. Weinmann M, Jeremic B, Toomes H et al. Treatment of lung cancer in the elderly: Part I. Non-small cell lung cancer. Lung Cancer 2003; 39: 233-53.
4. Peake MD, Thompson S, Lowe D et al. Ageism in management of lung cancer. Age Ageing 2003; 32: 171-7.
5. Ramsey SD, Howlader N, Etzione RD et al. Chemotherapy use, outcomes and costs for older persons with advanced non-small cell lung cancer: Evidence from surveillance, epidemiology and end-results-Medicare. J Clin Oncol 2004; 22: 4971-8.
6. Coebergh JW, Janssen-Heijnen ML, Post PN et al. Serious comorbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol 1999; 52: 1131-6.
7. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-11.
8. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-83.
9. Janssen-Heijnen MLG, Smulders S, Lemmens VEPP et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004; 59: 602-7.
10. de Rijke JM, Schouten LJ, ten Velde GPM et al. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of population-based study. Lung Cancer 2004; 46: 233-45.
11. Firat S, Pleister A, Byhardt RW et al. Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III non-small cell lung cancer (NSCLC). Am J Clin Oncol 2006; 29: 252-7.
12. Kurishima K, Satoh H, Ishikawa H et al. Lung cancer patients with cardio and cerebrovascular diseases. Oncol Rep 2001; 8: 1251-3.
13. Read WL, Tierney RM, Page NC et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004; 22: 3099-103.
14. Maoine P, Perrone F, Gallo C et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small cell lung cancer receiving chemotherapy: A prognostic analysis of the Multicenter Italian Lung Cancer in the Elderly Study. J Clin Oncol 2005; 23: 6865-72.
15. Booton R, Jones M, Thatcher N. Lung cancer 7: Management of lung cancer in elderly patients. Thorax 2003; 58: 711-20.
16. Gridelli C, Shepherd FA. Chemotherapy for elderly patients with non-small cell lung cancer. Chest 2005; 128: 947-57.
17. Kuo S-S, Yang Ch-H, Yu Ch-J et al. Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials. Lung Cancer 2005; 48: 275-80.
18. Gullón JA, Suárez I, Fernández R et al. Chemotherapy and survival in advanced non-small cell lung carcinoma: Is pneumologists' skepticism justified? Arch Bronconeumol 2006; 42: 273-7.
19. Langer CJ. Neglected and underrepresented subpopulations: Elderly and performance status 2 patients with advanced nonsmall cell lung cancer. Clin Lung Cancer 2006; 7(Suppl 4): S126-37.
20. Montazeri A, Milroy R, HoleD et al. Quality of life in lung cancer patients: As an important prognostic factor. Lung Cancer 2001; 31: 233-40.
21. Efficace F, Bottomely A, Smit EF et al. Is a patient's self-reported health related quality of life a prognostic factor for survival in non-small cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 2006; 17: 1698-704.
22. Jett JR, Schild SE, Keith RL et al. Treatment of non-small cell lung cancer, stage III B. ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 133: 266S-76S.
23. Socinsky MA, Crowell R, Hensing TE et al. Treatment of non-small cell lung cancer, stage IV. ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 133: 277S-89S.